NewEdge Wealth LLC boosted its holdings in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 23.0% in the fourth quarter, HoldingsChannel.com reports. The firm owned 8,943 shares of the company’s stock after acquiring an additional 1,673 shares during the period. NewEdge Wealth LLC’s holdings in HCA Healthcare were worth $4,175,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also recently added to or reduced their stakes in the business. Drucker Wealth 3.0 LLC boosted its holdings in HCA Healthcare by 6.9% in the fourth quarter. Drucker Wealth 3.0 LLC now owns 559 shares of the company’s stock worth $261,000 after purchasing an additional 36 shares during the period. Ethic Inc. boosted its holdings in HCA Healthcare by 35.0% in the fourth quarter. Ethic Inc. now owns 22,310 shares of the company’s stock worth $10,416,000 after purchasing an additional 5,781 shares during the period. Kessler Investment Group LLC boosted its holdings in HCA Healthcare by 1.2% in the fourth quarter. Kessler Investment Group LLC now owns 18,894 shares of the company’s stock worth $8,821,000 after purchasing an additional 227 shares during the period. Strengthening Families & Communities LLC lifted its stake in HCA Healthcare by 9.0% in the fourth quarter. Strengthening Families & Communities LLC now owns 763 shares of the company’s stock valued at $356,000 after buying an additional 63 shares during the last quarter. Finally, Generali Asset Management SPA SGR lifted its stake in HCA Healthcare by 63.8% in the fourth quarter. Generali Asset Management SPA SGR now owns 18,462 shares of the company’s stock valued at $8,619,000 after buying an additional 7,193 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.
Analyst Ratings Changes
A number of equities research analysts have issued reports on the company. Stephens cut their target price on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. The Goldman Sachs Group raised their target price on HCA Healthcare from $520.00 to $558.00 and gave the company a “buy” rating in a research note on Wednesday, January 28th. Sanford C. Bernstein cut their target price on HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating on the stock in a research note on Tuesday, April 28th. KeyCorp lowered their price target on HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. Finally, Wall Street Zen lowered HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Sixteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and an average price target of $517.82.
HCA Healthcare Stock Down 2.0%
NYSE:HCA opened at $426.58 on Tuesday. The business’s 50-day moving average price is $487.44 and its 200 day moving average price is $486.55. The firm has a market cap of $94.63 billion, a P/E ratio of 14.67, a PEG ratio of 1.38 and a beta of 1.18. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52.
HCA Healthcare (NYSE:HCA – Get Free Report) last released its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The firm had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.HCA Healthcare’s revenue was up 4.3% on a year-over-year basis. During the same period in the previous year, the firm earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Sell-side analysts expect that HCA Healthcare, Inc. will post 30.07 EPS for the current year.
HCA Healthcare Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.73%.
Insiders Place Their Bets
In other HCA Healthcare news, SVP Jennifer Berres sold 8,020 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the sale, the senior vice president directly owned 11,993 shares in the company, valued at approximately $6,171,357.94. This trade represents a 40.07% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Michael R. Mcalevey sold 1,694 shares of HCA Healthcare stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total value of $903,528.78. Following the sale, the executive vice president owned 8,853 shares of the company’s stock, valued at approximately $4,721,924.61. This represents a 16.06% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 13,714 shares of company stock worth $7,050,460. 1.50% of the stock is currently owned by company insiders.
About HCA Healthcare
HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Featured Stories
- Five stocks we like better than HCA Healthcare
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
